Esketamine vs. Traditional Antidepressants: How New Therapies Are Changing Treatment Timelines
Esketamine offers rapid relief for treatment-resistant depression, often working within hours or days. Unlike traditional antidepressants, esketamine targets the brain’s glutamate system to enhance neuroplasticity. FDA-approved Spravato is administered via nasal spray in certified clinics under medical supervision. PMC Heal integrates esketamine into personalized care plans, combining therapy, medication, and support. If you’ve struggled with […]
Is Ketamine an Opioid? Why It’s Different — And Why That Matters in Mental Health
Key Takeaways: Ketamine is not an opioid; it does not act on opioid receptors or carry the same risks of physical dependence, despite being used for pain relief in medical settings. Ketamine is classified as a dissociative anesthetic, working on NMDA receptors to promote glutamate activity and synaptic growth, which can rapidly relieve depression and […]
What to Expect During Your First Esketamine Treatment
Key Takeaways: Thorough screening ensures esketamine is safe and appropriate, with detailed assessments before starting treatment. Treatment sessions are calm and supervised, with self-administered nasal esketamine and a two-hour observation period. Post-session care focuses on safety, including monitoring, guidance on side effects, and requiring a ride home. Esketamine is part of a broader care plan, […]
How Long Does Ketamine Relief Last? What Patients Should Know About Duration and Effectiveness
Key Takeaways Relief from ketamine infusion therapy can last from days to weeks, depending on the patient and condition. Esketamine and ketamine both provide fast-acting relief but may require maintenance sessions for lasting benefits. Treatment duration is influenced by the method used, the condition being treated, and each patient’s unique response. Esketamine’s long-term side effects […]
How Ketamine Infusion Therapy Is Redefining Care for Depression and Anxiety
Key Takeaways Ketamine infusion delivers rapid symptom relief by targeting glutamate, not serotonin, offering hope for treatment-resistant depression and anxiety. Sessions are medically supervised, with tailored dosing and a calm clinical setting designed to prioritize patient safety and comfort. Most patients start with six infusions over 2–3 weeks, followed by ongoing maintenance based on individual […]
Is Ketamine Addictive? Separating Facts From Stigma in Modern Mental Healthcare
Key Takeaways Ketamine is not considered addictive when used in a medically supervised setting for mental health treatment. Ketamine is not an opioid and works through the brain’s glutamate system to support neuroplasticity. Clinical protocols, including tailored dosing and in-clinic supervision, greatly reduce misuse risk. Esketamine contraindications, such as certain health conditions, are evaluated before […]
